Antibody drug conjugates (ADC) : Current status and mapping of ADC:s in clinical programs

Antibody drug conjugates (ADC) : Current status and mapping of ADC:s in clinical programs

A literature study was performed on a new type of cancer medicine: antibody drug conjugates, or ADCs. These consist of a monoclonal antibody, chemically linked to a cytotoxic agent. What makes them unique is their selective toxicity against cancer cells. The first approval of such a pharmaceutical w...

Full description

Bibliographic Details
Main Authors:	Congreve, Samantha, Faris Elias, Reham, Tidestav, Gabriel, Zafranian, Venus
Format:	Others
Language:	English
Published:	Uppsala universitet, Institutionen för teknikvetenskaper 2018
Subjects:	ADC antibody drug conjugate biopharmaceuticals structure linker payload target conjugation market Chemical Engineering Kemiteknik
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-352917

Similar Items

Antibody–Drug Conjugates: The Last Decade
by: Nicolas Joubert, et al.
Published: (2020-09-01)

Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs)
by: Houzong Yao, et al.
Published: (2016-02-01)

Antibody–Drug Conjugates—A Tutorial Review
by: Stephanie Baah, et al.
Published: (2021-05-01)

The Analysis of Key Factors Related to ADCs Structural Design
by: Haichao Tang, et al.
Published: (2019-04-01)

Antibody–Drug Conjugates for Cancer Therapy
by: Umbreen Hafeez, et al.
Published: (2020-10-01)

Antibody Conjugates-Recent Advances and Future Innovations
by: Donmienne Leung, et al.
Published: (2020-01-01)

The Chemistry Behind ADCs
by: Vesela Kostova, et al.
Published: (2021-05-01)

Advances and Limitations of Antibody Drug Conjugates for Cancer
by: Candice Maria Mckertish, et al.
Published: (2021-07-01)

Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
by: Hao Chen, et al.
Published: (2017-08-01)

Design and Validation of Linkers for Site-Specific Preparation of Antibody–Drug Conjugates Carrying Multiple Drug Copies per Cysteine Conjugation Site
by: Amit Kumar, et al.
Published: (2020-09-01)

Antibody-Drug Conjugates: A Promising Novel Therapy for the Treatment of Ovarian Cancer
by: Aranzazu Manzano, et al.
Published: (2020-08-01)

Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review
by: Vittoria Perrotti, et al.
Published: (2021-06-01)

Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice
by: Christoph Mamot, et al.
Published: (2012-11-01)

Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: state of the art and future directions
by: Emanuela Ferraro, et al.
Published: (2021-08-01)

Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
by: Ricarda M. Hoffmann, et al.
Published: (2018-03-01)

Antibody–Drug Conjugates for the Treatment of Breast Cancer
by: Chiara Corti, et al.
Published: (2021-06-01)

Antibody-Drug Conjugates: The New Frontier of Chemotherapy
by: Sara Ponziani, et al.
Published: (2020-07-01)

Site-Specific Antibody Conjugation for ADC and Beyond
by: Qun Zhou
Published: (2017-11-01)

Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety
by: Yanming Wang, et al.
Published: (2020-03-01)

Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure
by: Jeffrey C. Umotoy, et al.
Published: (2021-07-01)

Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer
by: Efrat T. Harel, et al.
Published: (2019-11-01)

A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma
by: Ricarda M. Hoffmann, et al.
Published: (2020-04-01)

Recent advances of antibody drug conjugates for clinical applications
by: Pengxuan Zhao, et al.
Published: (2020-09-01)

Predictable Peptide Conjugation Ratios by Activation of Proteins with Succinimidyl Iodoacetate (SIA)
by: Ioana M. Abbas, et al.
Published: (2017-09-01)

Conjugates of Small Molecule Drugs with Antibodies and Other Proteins
by: Yang Feng, et al.
Published: (2014-01-01)

Antibody–Drug Conjugates for Cancer Therapy
by: Adam C. Parslow, et al.
Published: (2016-07-01)

Antibody–drug conjugates in solid tumors: a look into novel targets
by: Carmen Criscitiello, et al.
Published: (2021-01-01)

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
by: Emily Capone, et al.
Published: (2020-10-01)

Immunotoxins and Anticancer Drug Conjugate Assemblies: The Role of the Linkage between Components
by: Luigi Cattel, et al.
Published: (2011-07-01)

Antibody Drug Conjugates as Cancer Therapeutics
by: Pamela A. Trail
Published: (2013-02-01)

Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
by: Nirnoy Dan, et al.
Published: (2018-04-01)

Multiplex LC-MS/MS Assays for Clinical Bioanalysis of MEDI4276, an Antibody-Drug Conjugate of Tubulysin Analogue Attached via Cleavable Linker to a Biparatopic Humanized Antibody against HER-2
by: Morse Faria, et al.
Published: (2019-01-01)

Hydrophilic Monomethyl Auristatin E Derivatives as Novel Candidates for the Design of Antibody-Drug Conjugates
by: Filip S. Ekholm, et al.
Published: (2018-12-01)

Linkers Having a Crucial Role in Antibody–Drug Conjugates
by: Jun Lu, et al.
Published: (2016-04-01)

Molecular Consortia—Various Structural and Synthetic Concepts for More Effective Therapeutics Synthesis
by: Anna Pawełczyk, et al.
Published: (2018-04-01)

Antibody–Drug Conjugates for the Treatment of Acute Pediatric Leukemia
by: Jamie L. Stokke, et al.
Published: (2021-08-01)

A new and simple non-chromatographic method for isolation of drug/linker constructs: vc-MMAE evaluation
by: Meghdad Abdollahpour-Alitappeh, et al.
Published: (2017-10-01)

Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)—A Necessity for Future ADC Research and Development
by: Manar Hammood, et al.
Published: (2021-07-01)

Small-Format Drug Conjugates: A Viable Alternative to ADCs for Solid Tumours?
by: Mahendra P. Deonarain, et al.
Published: (2018-03-01)

Clinical Pharmacology of Antibody-Drug Conjugates
by: Iftekhar Mahmood
Published: (2021-05-01)